Published in Postgrad Med J on November 01, 1990
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Thrombosis in patients with the lupus anticoagulant. Ann Intern Med (1980) 4.02
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol (1985) 3.38
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med (1985) 2.62
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet (1983) 1.91
Anticardiolipin antibodies--clinical associations. Postgrad Med J (1986) 1.71
Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol (1990) 1.61
Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol (1988) 1.58
Lupus anticoagulants. Prog Hemost Thromb (1982) 1.56
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis (1989) 1.48
Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med (1985) 1.47
Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34
Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum (1987) 1.19
Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol (1988) 1.16
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis (1990) 1.14
Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al. Arthritis Rheum (1988) 1.11
Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1988) 1.10
The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum (1985) 1.09
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol (1987) 1.07
Antiphospholipid syndrome: linking many specialties. Ann Rheum Dis (1989) 0.99
Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives. Arthritis Rheum (1986) 0.99
Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril (1988) 0.86
Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin Rheumatol (1989) 0.84
The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med (1985) 0.84
Antiphospholipid antibodies in unselected patients with repeated abortion. Hum Reprod (1990) 0.78
[Antiphospholipid antibodies as markers of systemic lupus erythematosus]. Med Clin (Barc) (1987) 0.77
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Systemic lupus erythematosus. Lancet (2001) 4.18
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol (2000) 2.06
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]. Med Clin (Barc) (1994) 2.03
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
[50 years of LE cells: is it time for their retirement?]. Med Clin (Barc) (1998) 2.02
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases. Lupus (2009) 1.97
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) (2001) 1.97
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Seronegative antiphospholipid syndrome. Ann Rheum Dis (2003) 1.90
Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol (1989) 1.77
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76
Central nervous system lupus--diagnosis and treatment. J Rheumatol (1980) 1.75
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis (1989) 1.73
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) (2004) 1.68
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67
Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med (1994) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis (1982) 1.64
Deficiency of factor B of the complement system in sickle cell anaemia. Br Med J (1976) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Hypoadrenalism, Addison's disease and antiphospholipid antibodies. J Rheumatol (1991) 1.60
Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60
Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum (1979) 1.57
Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol (1977) 1.57
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56
Significance of persisting serologic abnormalities in SLE. Arthritis Rheum (1976) 1.56
Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56
The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56
The clavicle hook plate for Neer type II lateral clavicle fractures. J Orthop Trauma (2009) 1.55